Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents - Aix-Marseille Université Access content directly
Journal Articles Bioorganic and Medicinal Chemistry Year : 2017

Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents

Abstract

The synthesis of twenty-six 4-arylcoumarin analogues of combretastatin A-4 (CA-4) led to the identification of two new compounds (25 and 26) with strong cytotoxic activity. Both compounds had a high cytotoxic effect on a CA-4-resistant colon adenocarcinoma cell line (HT29D4). The compounds affected cell cycle progression characterized by a mitotic block. The activity of these compounds against microtubules both in vitro and in cells was examined and both compounds were found to potently inhibit in vitro microtubule formation via a sub-stoichiometric mode like CA-4. By immunofluorescence, it was observed that both compounds induced strong microtubule network disruption. Our results provide a strong experimental basis to develop new potent anti-tubulin molecules targeting CA-4-resistant cancer cells.
No file

Dates and versions

hal-01744155 , version 1 (27-03-2018)

Identifiers

Cite

Peggoty Mutai, Gilles Breuzard, Alessandra Pagano, Diane Allegro, Vincent Peyrot, et al.. Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents. Bioorganic and Medicinal Chemistry, 2017, 25 (5), pp.1652 - 1665. ⟨10.1016/j.bmc.2017.01.035⟩. ⟨hal-01744155⟩
47 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More